The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 09, 2019
Filed:
Oct. 25, 2016
Applicant:
Innopharma, Inc., New York, NY (US);
Inventors:
Udaya Toti, Monmouth Junction, NJ (US);
Shyamprasad Mukundan, Parsippany, NJ (US);
Sasank Chaitanya Kunadharaju, Edison, NJ (US);
Tushar Hingorani, Piscataway, NJ (US);
Kumaresh Soppimath, Monmouth Junction, NJ (US);
Satish Pejaver, Bridgewater, NJ (US);
Navneet Puri, Bridgewater, NJ (US);
Assignee:
InnoPharma, Inc., Piscataway, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 9/00 (2006.01); A61K 47/12 (2006.01); A61K 9/10 (2006.01); A61K 47/38 (2006.01); A61K 47/20 (2006.01); A61K 9/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A61K 9/10 (2013.01); A61K 47/12 (2013.01); A61K 47/20 (2013.01); A61K 47/38 (2013.01); A61K 9/146 (2013.01);
Abstract
A liquid pharmaceutical compositions comprising Aprepitant is preferably prepared as an oral suspension dosage form for the prevention and control of acute and delayed chemotherapy induced nausea and vomiting, and/or for prevention of postoperative nausea and vomiting.